Good morning! Stock futures for Tuesday, March 17, forecasted a 52-point decrease from yesterday's close. The DJIA Index surged 228 points...
Antibiotic-resistant microorganisms are turning into a national medical nightmare, and the need for new, more effective...
Last week's $45.2 billion
Pharmaceutical and biotech mergers and acquisitions (M&A) is on track to hand us the best year for non-mega merger deals since 2010 - which...
On Sunday, the world's largest independent biotechnology company, Amgen Inc. (Nasdaq:
